Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant herpes simplex gD vaccine

Recombinant herpes simplex gD vaccine

US Patent 5612041 · Granted Mar 18, 1997

Estimated economic value: $18,027,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Markers associated with arteriovascular events and methods of use thereof2017
Sodium channel blocker for treatment of loss of superficial sensitivity2015
Markers associated with arteriovascular events and methods of use thereof2015
Methods and compositions for detecting polynucleotides2011
Compositions and kits for treating influenza2011
Compositions and kits for treating influenza2010
Sequences from Piscirickettsia salmonis2010
Bioadhesive delivery system for transmucosal delivery of beneficial agents2009
Factor VIII:C nucleic acid molecules2006
Factor VIII:C nucleic acid molecules2006
Multiple epitope fusion protein2006
Helicobacter pylori diagnostics2005